Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
Respirics
company
About
Respirics is an inhalation drug products company focusing on the development and commercialization of therapeutic products.
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $3.40M
- Industries
- Biotechnology,Developer Platform,Therapeutics
- Founded date
- Jan 1, 2000
- Number Of Employee
- 1 - 10
- Operating Status
- Close
Respirics is an inhalation drug products company focusing on the development and commercialization of therapeutic products using the company's proprietary, customizable Acu-Breatheâ„¢ dry powder inhalers (DPIs). The company's strategy is to develop a suite of inhalation products for asthma and COPD, and to enter licensing and co-development programs with large or specialty pharmaceutical companies.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$3.40M
Respirics has raised a total of
$3.40M
in funding over 2 rounds. Their latest funding was raised on
Sep 27, 2005 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 27, 2005 | Series A | $3.40M | 1 |
Research Triangle Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Respirics is funded by 1 investors.
Research Triangle Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Research Triangle Ventures
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
